Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

EGLN1 anticorps (AA 350-426)

EGLN1 Reactivité: Humain WB, IHC, IP Hôte: Lapin Polyclonal unconjugated
N° du produit ABIN540735
  • Antigène Voir toutes EGLN1 Anticorps
    EGLN1 (Egl-9 Family Hypoxia Inducible Factor 1 (EGLN1))
    Épitope
    • 15
    • 10
    • 6
    • 6
    • 5
    • 3
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 350-426
    Reactivité
    • 63
    • 32
    • 17
    • 3
    • 3
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    Humain
    Hôte
    • 56
    • 6
    • 2
    Lapin
    Clonalité
    • 58
    • 6
    Polyclonal
    Conjugué
    • 35
    • 3
    • 3
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    Cet anticorp EGLN1 est non-conjugé
    Application
    • 55
    • 22
    • 17
    • 14
    • 13
    • 7
    • 5
    • 5
    • 4
    • 3
    • 3
    • 1
    • 1
    • 1
    Western Blotting (WB), Immunohistochemistry (IHC), Immunoprecipitation (IP)
    Fonction
    Rabbit polyclonal antibody raised against synthetic peptide of EGLN1.
    Specificité
    This antibody is specific to human HIF prolyl hydroxylase 2. There is 83 % homology between the immunogen used for this antibody and the rat and mouse proteins.
     Réactivité croisée
    Humain
    Immunogène
    A synthetic peptide corresponding to amino acids 350-426 of human EGLN1.
    Top Product
    Discover our top product EGLN1 Anticorps primaire
  • Indications d'application
    The optimal working dilution should be determined by the end user.
    Restrictions
    For Research Use only
  • Format
    Liquid
    Buffer
    In Tris-citrate/phosphate buffer, pH 7.0-8.0 (0.09 % sodium azide)
    Agent conservateur
    Sodium azide
    Précaution d'utilisation
    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Stock
    4 °C
    Stockage commentaire
    Store at 4°C. Do not freeze.
  • Wong, Goehring, Kapiloff, Langeberg, Scott: "mAKAP compartmentalizes oxygen-dependent control of HIF-1alpha." dans: Science signaling, Vol. 1, Issue 51, pp. ra18, (2008) (PubMed).

    Colla, Tagliaferri, Morandi, Lunghi, Donofrio, Martorana, Mancini, Lazzaretti, Mazzera, Ravanetti, Bonomini, Ferrari, Miranda, Ladetto, Neri, Neri, Greco, Mangoni, Bonati, Rizzoli, Giuliani et al.: "The new tumor-suppressor gene inhibitor of growth family member 4 (ING4) regulates the production of proangiogenic molecules by myeloma cells and suppresses hypoxia-inducible factor-1 alpha ..." dans: Blood, Vol. 110, Issue 13, pp. 4464-75, (2007) (PubMed).

    Ietta, Wu, Winter, Xu, Wang, Post, Caniggia: "Dynamic HIF1A regulation during human placental development." dans: Biology of reproduction, Vol. 75, Issue 1, pp. 112-21, (2006) (PubMed).

    Baek, Mahon, Oh, Kelly, Krishnamachary, Pearson, Chan, Giaccia, Semenza: "OS-9 interacts with hypoxia-inducible factor 1alpha and prolyl hydroxylases to promote oxygen-dependent degradation of HIF-1alpha." dans: Molecular cell, Vol. 17, Issue 4, pp. 503-12, (2005) (PubMed).

  • Antigène
    EGLN1 (Egl-9 Family Hypoxia Inducible Factor 1 (EGLN1))
    Autre désignation
    EGLN1 / PHD2 (EGLN1 Produits)
    Synonymes
    anticorps EGLN1, anticorps egln2, anticorps phd2, anticorps zgc:92314, anticorps AI503754, anticorps C1orf12, anticorps HIF-PH2, anticorps HPH-2, anticorps Hif-p4h-2, anticorps ORF13, anticorps Phd2, anticorps SM-20, anticorps PHD-2, anticorps PHD2, anticorps ECYT3, anticorps HIFPH2, anticorps HPH2, anticorps SM20, anticorps ZMYND6, anticorps egl nine homolog 1 (C. elegans), anticorps egl-9 family hypoxia inducible factor 1, anticorps egl-9 family hypoxia-inducible factor 1 S homeolog, anticorps egl-9 family hypoxia-inducible factor 1b, anticorps egl-9 family hypoxia-inducible factor 1, anticorps EGLN1, anticorps egln1.S, anticorps egln1b, anticorps Egln1
    ID gène
    54583
    Pathways
    cAMP Metabolic Process, L'effet Warburg
Vous êtes ici:
Support technique